This list is an analysis based on recent market events. It's not an investment recommendation.
About
DongKoo Bio&Pharma. Co., Ltd. researches, develops, manufactures, and sells medicines in South Korea. The company offers prescribed medicines, such as liver disease, skeletal muscle relaxant, endocrine system, brain nervous system, urogenital, antiobestic, digestive system, circulatory organ, allergenic, mental disease, oral dermatology, external preparation of dermatology, antiseptic, antiviral, antifungal, antihistamines, antifebrile and anti-inflammatory analgesic, respiratory system, digestant, antiplatelet, other analgesics and antipyretics, nootropics and neurotonics, nonsteroidal anti-inflammatory, and oral hypoglycemic medicines; and antiphlogisnc enzyme, ophthalmic, dermatology external, and decongestants and nasal preparations, as well as non-selective a, ß-blockers and H+ pump inhibitors. It also provides cosmetic products under the CELL BLOOM brand; and SmartX, a kit-type SVF separation medical device for use in cosmetic surgery/anti-aging clinics and medical/treatments. The company was founded in 1970 and is headquartered in Seoul, South Korea.
The current price of 006620.KQ is ₩3,520 KRW — it has increased by +0% in the past 24 hours. Watch Dongkoo Bio&Pharma. stock price performance more closely on the chart.
What is Dongkoo Bio&Pharma. stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on KOSDAQ exchange Dongkoo Bio&Pharma. stocks are traded under the ticker 006620.KQ.
Is Dongkoo Bio&Pharma. stock price growing?▼
006620.KQ stock has risen by +0.86% compared to the previous week, the month change is a -4.61% fall, over the last year Dongkoo Bio&Pharma. has showed a -36.8% decrease.
What is Dongkoo Bio&Pharma. market cap?▼
Today Dongkoo Bio&Pharma. has the market capitalization of 95.19B
What is Dongkoo Bio&Pharma. revenue for the last year?▼
Dongkoo Bio&Pharma. revenue for the last year amounts to 242.69B KRW.
What is Dongkoo Bio&Pharma. net income for the last year?▼
006620.KQ net income for the last year is 50.27B KRW.
Does Dongkoo Bio&Pharma. pay dividends?▼
Yes, 006620.KQ dividends are paid annual. The last dividend per share was 120 . As of today, Dividend Yield (FWD)% is 3.41%.
How many employees does Dongkoo Bio&Pharma. have?▼
As of September 23, 2026, the company has 331 employees.
In which sector is Dongkoo Bio&Pharma. located?▼
Dongkoo Bio&Pharma. operates in the Health & Wellness sector.
When did Dongkoo Bio&Pharma. complete a stock split?▼
The last stock split for Dongkoo Bio&Pharma. was on March 02, 2021 with a ratio of 2:1.
Where is Dongkoo Bio&Pharma. headquartered?▼
Dongkoo Bio&Pharma. is headquartered in Seoul, South Korea.